Subscriber login:
Remember me
COMBINING
UNCOMMON EXPERTISE
WITH PROPRIETARY DATA
TO DRIVE UNIQUE INSIGHT
IPD Analytics identifies, projects, and quantifies the impact of competitive-landscape shifts in the pharmaceutical and biologic market to offer:
-
Industry-leading drug life-cycle analysis
-
Clinical, formulary, procurement, and inventory-control insights for payers, providers, and suppliers
-
Brand and generic market impact forecasts
-
Pharmaceutical coding and reimbursement information
THE INDUSTRY LEADER
AN INDEPENDENT, THIRD-PARTY SOURCE
We take data from thousands of sources, combine it with proprietary research, and work to normalize, analyze, and summarize...
With a unique team of experts, including:
Former Federal Circuit Patent Clerks and Litigators
Payor and Provider
Clinical Pharmacists
Brand and Generic Financial Forecasters from
Major Manufacturers
PhD Scientists with Pharmacy and Bioscience Backgrounds
Team of Researchers and Patent Searchers Utilizing Proprietary Data Aggregation Tools
We develop the
foundation that powers our solutions:
loss-of-exclusivity
timing
And provide meaningful, tailored insights for
specific use cases:
Key Litigation Updates & Analysis
Critical Headlines &
Day-by-day Trial Updates
Drug & Disease-Class Reviews
Formulary Planning Guidance
Loss-of-Exclusivity and
Market-Impact Forecasts
Analog Library with Accompanying Qualitative Analysis
Pipeline-Planning Tools
Coding & Reimbursement Insights
Drug-Price Tools
Scenario Analysis
We deliver these insights in multiple, easily consumable formats:
To serve stakeholders and institutional investors across the pharmaceutical industry:
Platform
Email Alerts
Direct Consultations
Podcast Episodes
Reports
Data Downloads
Manufacturers:
Brand Manufacturers
Generic Manufacturers
Specialty Drug Manufacturers
Active Ingredient Manufacturers
Institutional Investors:
Investment Managers
Hedge Funds
Mutual Funds
Sovereign Funds
Pension Funds
THE INDUSTRY LEADER
AN INDEPENDENT, THIRD-PARTY SOURCE
Since 2002, IPD Analytics has offered solutions that:
-
Deliver compelling insight and unique data assets to solve complex, multi-layered problems
-
Enable efficiency and transparency in an opaque pharmaceutical market
-
Offer a comprehensive look at the past to help predict future market shifts
We take data from thousands of sources, combine it with proprietary research, and work to normalize, analyze, and summarize...
With a unique team of experts, including:
Former Federal Circuit Clerks, Patent Attorneys, and Litigators
Payer and Provider
Clinical Pharmacists
Brand and Generic Financial Forecasters from
Major Manufacturers
PhD Scientists with Pharmacy and Bioscience Backgrounds
Team of Researchers and Patent Searchers Utilizing Proprietary Data-Aggregation Tools
We develop the
foundation that powers our solutions:
loss-of-exclusivity
timing and innovative, product-launch tracking
And provide meaningful, tailored insights for
specific use cases:
Drug Litigation Updates & Analysis
Critical Headlines &
Day-by-Day Trial Updates
Drug & Disease-Class Reviews
Formulary Planning Guidance
Loss-of-Exclusivity and
Market-Impact Forecasts
Clinical Pipeline Tracking Tools
Coding & Reimbursement Solutions
Drug-Price and Rebate Monitoring Tools
Limited Distribution, Formulary Coverage, Clinical Criteria, Patient Financial Assistance, Clinical Guidelines, and Therapy Cost Analysis
Brand, Generic, and Biosimilar Launch Forecasts
Budget Impact Models
Curated Datasets, Visualizations, and Workflow Integrations
We deliver these insights in multiple, easily consumable formats:
To serve stakeholders and institutional investors across the pharmaceutical industry:
Online Platform
Email Alerts
Phone Consultations
Podcast Episodes
Reports
Data Downloads
Manufacturers:
Brand Manufacturers
Generic Manufacturers
Specialty-Drug Manufacturers
Active-Ingredient Suppliers
Payers, Providers, & Suppliers:
Payers
Health Systems
Wholesalers
Specialty & Retail Pharmacies
Long-Term Care Facilities
IDNs
GPOs
PBMs
Institutional Investors:
Investment Managers
Hedge Funds
Mutual Funds
Sovereign Funds
Pension Funds
Private Equity
OUR SOLUTIONS
IPD Analytics provides actionable insights to drive decisions.
We offer subscription-based access to our proprietary platforms, consultations, real-time email alerts, comprehensive reports, data downloads, podcast episodes, and more.
Pharmaceuticals | Biotech | Biosimilars
Global Life-Cycle Solutions
Clinical Pharmacy Solutions
Market Forecasting Solutions
OTHER INDUSTRIES
ALL INDUSTRIES
PODCAST
IPD's Drug & Clinical Review:
The Premier Podcast for Drug Intelligence and Management Strategy
Within each episode, IPD's Executive Clinical Pharmacy Team discusses:
-
Drug pipeline intelligence and clinical strategy surrounding loss of exclusivity, high-cost and complex drugs, formulary planning, and pharmacy and therapeutics management
-
Impactful generic, brand, and biosimilar launches coming
down the pipeline
-
Strategies to improve outcomes, lower pharmacy spend, and optimize formulary design
-
Popular questions frequently asked by payers, providers, and manufacturers around the country